◆Taniwaki H, Ishimura E, Kawagishi T, Matsumoto N, Hosoi M, Emoto M, Shoji T, Shoji S, Nakatani T, Inaba M, Nishizawa Y.
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Diabetes Care. 2003 Jan;26(1):132-7.

◆Komatsu M, Kawagishi T, Emoto M, Shoji T, Yamada A, Sato K, Hosoi M, Nishizawa Y.
ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes.
Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H557-61.

◆Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y.
Advanced atherosclerosis in predialysis patients with chronic renal failure.
Kidney Int. 2002 Jun;61(6):2187-92.

◆Matsumoto N, Ishimura E, Taniwaki H, Emoto M, Shoji T, Kawagishi T, Inaba M, Nishizawa Y.
Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus.
Nephrol Dial Transplant. 2002 Apr;17(4):608-13.

◆Taniwaki H, Shoji T, Emoto M, Kawagishi T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y.
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus.
Atherosclerosis. 2001 Sep;158(1):207-14.

◆Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y.
Atherogenic lipoprotein changes in diabetic nephropathy.
Atherosclerosis. 2001 Jun;156(2):425-33.

◆Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y.
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Diabetes Care. 2001 Mar;24(3):533-8.

◆Shoji T, Kawagishi T, Emoto M, Maekawa K, Taniwaki H, Kanda H, Nishizawa Y.
Additive impacts of diabetes and renal failure on carotid atherosclerosis.
Atherosclerosis. 2000 Nov;153(1):257-8.

◆Kurioka Y, Inaba M, Kawagishi T, Emoto M, Kumeda Y, Inoue Y, Morii H, Nishizawa Y.
Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy.
Eur J Endocrinol. 2001 Feb;144(2):99-107.

◆Shoji T, Kimoto E, Yamada A, Emoto M, Kawagishi T, Tabata T, Nishizawa Y.
Elevated plasma free apo(a) levels in hemodialysis patients.
Nephron. 2000 Nov;86(3):389-90.

◆Matsumoto N, Ishimura E, Taniwaki H, Emoto M, Shoji T, Kawagishi T, Inaba M, Nishizawa Y.
Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure.
Nephron. 2000 Sep;86(1):44-51.

◆Taniwaki H, Ishimura E, Emoto M, Kawagishi T, Matsumoto N, Shoji T, Okamura T, Inaba M, Nishizawa Y.
Relationship between urinary albumin excretion and glomerular filtration rate in normotensive, nonproteinuric patients with type 2 diabetes mellitus.
Nephron. 2000 Sep;86(1):36-43.

◆Inaba M, Morii H, Katsumata T, Goto H, Ishimura E, Kawagishi T, Kamao M, Okano T, Nishizawa Y.
Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats.
J Nutr. 2000 Jun;130(6):1543-7.

◆Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y.
Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):703-7.

◆Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H.
Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes.
Osteoporos Int. 1999;9(6):525-31.

◆Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, Emoto M, Kawagishi T, Morii H.
Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Atherosclerosis. 2000 Jan;148(1):171-7.

◆Taniwaki H, Kawagishi T, Emoto M, Shoji T, Hosoi M, Kogawa K, Nishizawa Y, Morii H.
Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
Diabetes Care. 1999 Nov;22(11):1858-64.

◆Taniwaki H, Kawagishi T, Emoto M, Shoji T, Kanda H, Maekawa K, Nishizawa Y, Morii H.
Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
Diabetes Care. 1999 Nov;22(11):1851-7.

◆Kawagishi T, Matsuyoshi M, Emoto M, Taniwaki H, Kanda H, Okuno Y, Inaba M, Ishimura E, Nishizawa Y, Morii H.
Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes.
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2509-16.

◆Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H.
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes Care. 1999 May;22(5):818-22.

◆Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H.
Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Kidney Int. 1999 Mar;55(3):1019-27.

◆Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, Okuno Y, Morii H.
Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
Diabetes Care. 1998 Nov;21(11):1848-55.

◆Shimada H, Miki T, Kyogoku I, Kawagishi T, Inaba M, Okuno Y, Nishizawa Y, Morii H.
[Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement]
No To Shinkei. 1998 Sep;50(9):817-20. Japanese.

◆Takahashi T, Nishizawa Y, Emoto M, Kawagishi T, Matsumoto N, Ishimura E, Inaba M, Okuno Y, Shimada H, Morii H.
Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patients.
Diabetes Care. 1998 Sep;21(9):1495-501.

◆Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, Izumotani K, Shoji T, Ishimura E, Inaba M, Okuno Y, Morii H.
Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.
Diabetes Care. 1998 Jul;21(7):1178-82.

◆Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H.
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
J Am Soc Nephrol. 1998 Jul;9(7):1277-84.

◆Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H.
Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.
J Nephrol. 1998 Mar-Apr;11(2):83-6.

◆Morii H, Shioi A, Inaba M, Goto H, Kawagishi T, Nakatsuka K, Nishizawa Y, Takahashi H, Sone H, Katsumata T.
Significance of albumin in the pathogenesis of osteoporosis: bone changes in genetically analbuminemic rats and rats fed a low albumin diet.
Osteoporos Int. 1997;7 Suppl 3:S30-5.

◆Kawasaki I, Ishimura E, Shioi A, Emoto M, Kawagishi T, Goto K, Wakasa K, Nishizawa Y, Morii H.
Renal dysfunction worsened by superimposition of IgA glomerulonephritis in a patient with overt diabetic nephropathy.
Nephron. 1998;78(2):232-4.

◆Shoji T, Nishizawa Y, Kawagishi T, Emoto M, Morii H. Related Articles, Links
Secondary hyperparathyroidism, decreased hepatic triglyceride lipase, elevated intermediate density lipoprotein and atherosclerosis in hemodialysis patients.
Nephron. 1998;78(1):121-2.

◆Kawagishi T, Morii H.
[Diabetic osteopenia]
Nippon Rinsho. 1997 Oct;55 Suppl:935-9. Review. Japanese.

◆Nishizawa Y, Shoji T, Kawagishi T, Morii H. Related Articles, Links
Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
Kidney Int Suppl. 1997 Nov;62:S90-2. Review.

◆Kawagishi T, Nishizawa Y, Taniwaki H, Tanaka S, Okuno Y, Inaba M, Ishimura E, Emoto M, Morii H.
Relationship between gastric emptying and an alpha-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients.
Diabetes Care. 1997 Oct;20(10):1529-32.

◆Emoto M, Nishizawa Y, Maekawa K, Kawagishi T, Kogawa K, Hiura Y, Mori K, Tanaka S, Ishimura E, Inaba M, Okuno Y, Morii H.
Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy.
Metabolism. 1997 Sep;46(9):1013-8.

◆Shoji T, Nishizawa Y, Emoto M, Maekawa K, Hiura Y, Tanaka S, Kawagishi T, Okuno Y, Morii H.
Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM.
Diabetologia. 1997 Jun;40(6):676-9.

◆Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H.
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Atherosclerosis. 1997 Jun;131(2):229-36.

◆Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S, Maekawa K, Hosoi M, Inaba M, Emoto M, Morii H.
Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography.
Kidney Int. 1997 Jun;51(6):1920-7.

◆Kawagishi T, Nishizawa Y, Emoto M, Maekawa K, Okuno Y, Taniwaki H, Inaba M, Ishimura E, Morii H.
Gastric myoelectrical activity in patients with diabetes. Role of glucose control and autonomic nerve function.
Diabetes Care. 1997 May;20(5):848-54.

◆Kogawa K, Nishizawa Y, Hosoi M, Kawagishi T, Maekawa K, Shoji T, Okuno Y, Morii H.
Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.
Diabetes. 1997 Apr;46(4):682-7.

◆Ishimura E, Nishizawa Y, Emoto M, Shoji T, Inaba M, Kawagishi T, Morii H.
Therapeutic effect of sarpogrelate, a new 5-hydroxytryptamine receptor 2A antagonist, on diabetic nephropathy and neuropathy.
Nephron. 1997;76(2):227-9.

◆Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, Emoto M, Fukumoto S, Shioi A, Shoji T, Inaba M, Okuno Y, Morii H.
Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.
Circulation. 1996 Aug 15;94(4):704-7.

◆Ishimura E, Okamura T, Masaki H, Hiura Y, Kawagishi T, Inaba M, Nishizawa Y, Ochi H, Morii H.
Amyloid goiter: radiological study in a case presenting hypothyroidism.
Horm Metab Res. 1996 Jan;28(1):27-31.

◆Fukumoto S, Ishimura E, Hosoi M, Kawagishi T, Kawamura T, Isshiki G, Nishizawa Y, Morii H.
Angiotensin converting enzyme gene polymorphism and renal artery resistance in patients with insulin dependent diabetes mellitus.
Life Sci. 1996;59(8):629-37.

◆Kawagishi T, Nishizawa Y, Emoto M, Konishi T, Maekawa K, Hagiwara S, Okuno Y, Inada H, Isshiki G, Morii H.
Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy.
Diabetes Care. 1995 Dec;18(12):1544-9.

◆Takuma H, Kawagishi T, Kyogoku I, Okuno Y, Nishizawa Y, Morii H.
A case of primary and generalized allergy to human insulin with no history of any prior insulin exposure.
Diabetes Res Clin Pract. 1995 Oct;30(1):69-73.

◆Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H.
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.
Kidney Int. 1995 Sep;48(3):820-6.

◆Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H.
Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
J Bone Miner Res. 1995 Jul;10(7):1050-6.

◆Kawagishi T, Nishizawa Y, Emoto M, Kawasaki K, Shoji S, Inaba M, Miki T, Morita A, Tabata T, Inoue T, et al.
Growth of parathyroid gland in uremic patients on maintenance hemodialysis.
Miner Electrolyte Metab. 1995;21(1-3):104-8.

◆Kawagishi T, Nishizawa Y, Okuno Y, Shimada H, Inaba M, Konishi T, Morii H.
Antroduodenal motility and transpyloric fluid movement in patients with diabetes studied using duplex sonography.
Gastroenterology. 1994 Aug;107(2):403-9.

◆Ishimura E, Goto K, Kawagishi T, Shoji S, Okuno Y, Nishizawa Y, Morii H.
Combination of glomerulonephritis with diabetic glomerulopathy in a patient with diabetes mellitus due to autoantibody to insulin receptor.
Nephron. 1994;66(1):105-7.

◆Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H. Related Articles, Links
Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy.
Am J Gastroenterol. 1993 Jun;88(6):933-8.

◆Okuno Y, Nishizawa Y, Kawagishi T, Morii H. Related Articles, Links
In vivo and in vitro effects of glucocorticoids on glucose transport in human polymorphonuclear leukocytes.
Horm Metab Res. 1993 Mar;25(3):165-9.

◆Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H. Related Articles, Links
Segmental gut transit in diabetes mellitus: effect of cisapride.
Diabetes Res Clin Pract. 1992 Aug;17(2):137-44.

◆Okuno Y, Nishizawa Y, Kawagishi T, Sekiya K, Shoji T, Morii H.
Transport of 1,5-anhydro-D-glucitol into human polymorphonuclear leukocytes.
J Biochem (Tokyo). 1992 Jan;111(1):99-102.

◆Kawagishi T, Sekiya K, Okuno Y, Miki T, Nishizawa Y, Morii H.
Calcium metabolism in diabetes mellitus.
J Nutr Sci Vitaminol (Tokyo). 1991 Dec;37 Suppl:S51-6.

◆Kawagishi T, Morii H, Nakatsuka K, Sasao K, Kawasaki K, Miki T, Nishizawa Y.
Parathyroid hormone secretion in diabetes mellitus.
Contrib Nephrol. 1991;90:217-22.

◆Shoji T, Nishizawa Y, Toyokawa A, Kawagishi T, Okuno Y, Morii H.
Decreased albuminuria by pravastatin in hyperlipidemic diabetics.
Nephron. 1991;59(4):664-5.

◆Kawagishi T.
[The effect of growth hormone-releasing factor (GRF) on secretion of insulin, glucagon and somatostatin from perfused rat pancreas]
Nippon Naibunpi Gakkai Zasshi. 1990 May 20;66(5):557-71. Japanese.

◆Watanobe H, Kawagishi T, Hirai Y, Sato T, Tsutsui M, Kamata Y, Takebe K.
Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.
Acta Endocrinol (Copenh). 1985 Nov;110(3):302-7.